News

BD announces wearable injector trial for subcutaneous delivery of biologics
The prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Pharmabiz2d
BD reports first pharma-sponsored clinical trial using BD Libertas Wearable Injector technology for biologic drugs
Franklin Lakes, New Jersey Thursday, July 24, 2025, 14:00 Hrs [IST] ...
Drug Delivery Business2d
BD announces first pharma-sponsored clinical trial for wearable injector
BD (NYSE:BDX) today announced the first pharma-sponsored combination product clinical trial using its wearable injector technology.
Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend
Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership ...
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable ...
TipRanks on MSN3d
Becton Dickinson announces BD Libertas combination product clinical trial
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...